Orodispersible donepezil

Easai and Pfizer have launched Aricept Evess, an orodispersible tablet containing 5mg or 10mg donepezil hydrochloride.

The orodispersible tablet should be placed on the tongue and given with or without water. Like Aricept film-coated tablets, Aricept Evess is indicated for the symptomatic treatment of mild to moderately severe Alzheimer's dementia. The orodispersible tablets are bioequivalent to the film-coated tablets; the dose recommendations for both formulations are the same.

Further information: Eisai-Pfizer 0208 6001400

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases